methylnitrosourea has been researched along with Hypercalcemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adorini, L; Atalla, N; Buckley, B; Conney, AH; Lee, HJ; Lin, X; Lou, YR; Lu, G; Maehr, H; Paul, S; Suh, N; Thomas, PE; Uskokovic, M; Yang, I; Zheng, X | 1 |
| Binderup, L; Bramm, E; Colston, KW; Hamberg, KJ; Pirianov, G | 1 |
2 other study(ies) available for methylnitrosourea and Hypercalcemia
| Article | Year |
|---|---|
Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.
Topics: Animals; Calcitriol; Carcinoma; Cell Transformation, Neoplastic; Cells, Cultured; Female; Humans; Hypercalcemia; Incidence; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mice, SCID; Models, Biological; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Xenograft Model Antitumor Assays | 2008 |
Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Calcitriol; Dose-Response Relationship, Drug; Female; Hypercalcemia; Mammary Neoplasms, Animal; Methylnitrosourea; Neoplasms, Experimental; Rats; Rats, Wistar | 2003 |